SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The December 2021 quarter revenue stood at Rs. 5551.40 millions, up 8.21% as compared to Rs. 5130.10 millions during the corresponding quarter last year.The Company to register a -65.10%  fall in the net profit for the quarter ended December 2021.Operating profit for the quarter ended December 2021 decreased to 680.90 millions as compared to 1650.60 millions of corresponding quarter ended December 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 5551.40 5130.10 8.21 16115.30 15066.00 6.96 19669.80 18944.70 3.83
Other Income 88.80 78.10 13.70 251.10 180.90 38.81 243.00 160.20 51.69
PBIDT 680.90 1650.60 -58.75 2382.70 4987.60 -52.23 6161.40 5899.00 4.45
Interest 22.90 14.60 56.85 59.50 43.90 35.54 58.30 209.30 -72.15
PBDT 658.00 1636.00 -59.78 2183.90 4943.70 -55.82 6103.10 5689.70 7.27
Depreciation 111.30 99.70 11.63 322.50 289.50 11.40 389.20 357.30 8.93
PBT 546.70 1536.30 -64.41 1861.40 4654.20 -60.01 5713.90 5332.40 7.15
TAX 146.00 388.20 -62.39 482.30 961.10 -49.82 1268.30 1719.50 -26.24
Deferred Tax 2.50 1.10 127.27 -0.40 -217.90 -99.82 -187.20 10.50 -1882.86
PAT 400.70 1148.10 -65.10 1379.10 3693.10 -62.66 4445.60 3612.90 23.05
Equity 587.10 587.10 0.00 587.10 587.10 0.00 587.10 568.90 3.20
PBIDTM(%) 12.27 32.17 -61.88 14.79 33.11 -55.34 31.32 31.14 0.60

IOL Chem & Pharma Share Price

95.95 1.29 (1.36%)
06-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1850.40
Dr. Reddys Lab 1310.50
Cipla 1365.25
Zydus Lifesciences 939.10
Lupin 2442.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×